CAS 331744-72-0

Fórmula: C30H30N2O7

InChI: InChI=1S/C30H30N2O7/c1-20(32(19-28(33)34)30(35)39-26-15-13-24(36-3)14-16-26)22-9-11-25(12-10-22)37-18-17-27-21(2)38-29(31-27)23-7-5-4-6-8-23/h4-16,20H,17-19H2,1-3H3,(H,33,34)

Clave InChI: CUADMYMMZWFUCY-UHFFFAOYSA-N

SMILES: CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)C(C)N(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC

Peliglitazar racemate

CAS: 331744-72-0

Peliglitazar racemate

Fórmula: C₃₀H₃₀N₂O₇

Pureza: ≥95%

Peso molecular: 530.57

Ref: 54-BUP21545

Peliglitazar racemate

CAS: 331744-72-0

Fórmula: C₃₀H₃₀N₂O₇

Peso molecular: 530.5684

Ref: IN-DA01EOP5

Peliglitazar racemate

CAS: 331744-72-0

Peliglitazar is a ligand that binds to the glucagon-like peptide-1 receptor, activating it. This activation is thought to be responsible for the insulin-sensitizing effects of this drug. Peliglitazar has been shown to increase the activity of ion channels and stimulate the release of neurotransmitters. It also inhibits the production of amyloid beta by inhibiting protein interactions with its receptor. This drug has been used as a research tool in cell biology and biochemistry laboratories, but is not approved for use in humans.

Fórmula: C₃₀H₃₀N₂O₇

Pureza: Min. 95%

Peso molecular: 530.6 g/mol

Ref: 3D-GNA74472

Peliglitazar racemate

CAS: 331744-72-0

Peliglitazar racemate(BMS 426707-01 racemate) is the racemate of Peliglitazar.Peliglitazar racemate may be used as a potential antidiabetic and anti-obesity

Fórmula: C₃₀H₃₀N₂O₇

Pureza: 97.75%

Forma y color: Solid

Peso molecular: 530.57

Ref: TM-T12400